-The Hindu Communist Party of India (Marxist) Polit Bureau member Brinda Karat on Thursday demanded action against those responsible for allowing clinical trials of the human papillomavirus (HPV) vaccine in Andhra Pradesh and Gujarat without following the guidelines and ethics. Speaking at a seminar organised by the All-India Democratic Women's Association (AIDWA) here on “Cervical Cancer Vaccine — Consequences” the CPI(M) Rajya Sabha member said the poor in the country were...
More »SEARCH RESULT
Meet Ramdev, the landlord by Man Mohan
Yoga guru Baba Ramdev currently hitting headlines for his crusade against corruption and billions of dollars Indian black money stashed in Swiss and tax heaven banks is a “big landlord”. The 47-year-old “Bal Brahmchari” Ramdev, who was born as Ramkrishna Yadav in Alipur village, district Mahendragarh (Haryana), ‘owns’ huge tracts of land, that includes 261.468 hectares (644 acres) , worth hundreds of crores at the current market rate, around his yoga...
More »Slaving for their dowry by Kalpana Sharma
How the global garment industry is using regressive customs in Tamil Nadu, enabling it to exploit young women workers… Behind the smiling exterior of a fast-growing economy lie the tears and tragedies of women like these workers. Girls. Dowry. The two go together. No matter what you do to separate them, they somehow get conjoined, like twins that have remained connected in one body. We are told this is one of the...
More »CPI(M) opposes FDI in multi-brand retail trade
-The Hindu This pro-MNC neo-liberal framework will hit Indians It's a ploy to push for more sops to MNCs The CPI(M) on Saturday opposed the move to allow foreign direct investment (FDI) in multi-brand retail trade and called upon political parties and organisations to protest against this retrograde move. The CPI(M) Polit Bureau, in a statement, opposed the suggestion by the Inter-Ministerial Group on Inflation headed by the Chief Economic Adviser and said...
More »Details of patented drugs to be made public by CH Unnikrishnan
To increase transparency, India’s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price. Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has...
More »